/
Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States.
Mentions
1 mention · latest on 21 Sept 2026
See which tracked investors hold Supernus Pharmaceuticals, Inc. →Ownership and position changes on OwnershipTrace